Journal of the American Society of Nephrology·YesterdayA Microsimulation of Eligibility for Cardiorenal Combination Treatment and Potential Deaths AvertedComputational studyInterventionsPaper
European Journal of Heart Failure·6 OctKidney function decline, heart failure hospitalization, and the effect of empagliflozin in heart failure: an EMPEROR-pooled analysisTrial in peopleInterventionsPaper
ESC Heart Failure·18 SepNeutrophil-to-Lymphocyte Ratio in Patients With Heart Failure: Findings From The EMPEROR ProgramTrial in peopleBiomarkersPaper
European Journal of Heart Failure·16 SepMortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trialRandomised trial in peopleInterventionsPaper
JACC Heart Failure·3 SepResidual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes: Look AHEAD Ancillary StudyRandomised trial in 1,902 peopleHeart failurePaper
JACC Advances·27 AugINSIGHT Model: Explainable Artificial Intelligence for Real-World EHR-Based Screening of Transthyretin Amyloidosis CardiomyopathyComputational studyBiomarkersPaper
European Journal of Heart Failure·25 AugHeart Failure and Cancer: Incidence and Mortality Patterns, A Systematic Review and Meta-analysisReviewPopulationsPaper
The American Journal of Cardiology·21 AugThe Cancer-associated Lipid Paradox: Implications for Cardiovascular Risk and Lipid ManagementReviewMechanismsPaper
ESC Heart Failure·18 AugDifferential Rates of Guideline-Directed Medical Therapy Modification in C-MIC and Control Patients: Results from the C-MIC II TrialTrial in peopleInterventionsPaper
Journal of Cardiac Failure·8 AugImpact of Empagliflozin on Serum Calcium and Phosphate in Heart FailureRandomised trial in 9,718 peopleEmpagliflozinPaper
AHA Scientific Sessions 2025 Abstract·3 NovAssociations of baseline and longitudinal changes in MASLD with risk of heart failure events in type 2 diabetes and overweight or obesity: the Look Action for Health in Diabetes (Look AHEAD) Trial Liver Ancillary StudyTrial in peoplePopulationsPaper
AHA Scientific Sessions 2025 Abstract·3 NovIntensive lifestyle intervention, MASLD, and cardiovascular outcomes in type 2 diabetes and overweight or obesity: the Look Action for Health in Diabetes (Look AHEAD) trial Liver Ancillary StudyTrial in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovDual Therapy With Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Is Associated With Improved Outcomes in Patients With Heart Failure: A Real-World Propensity-Matched Cohort StudyStudy in peopleInterventionsPaper
AHA Scientific Sessions 2025 Abstract·3 NovChronic Kidney Disease with Inflammation and Incident Coronary Heart Disease in Black Adults from the Jackson Heart StudyStudy in peoplePopulationsPaper
AHA Scientific Sessions 2025 Abstract·3 NovA Contemporary Machine Learning-Based Risk Stratification for Mortality and Hospitalization in Heart Failure with Preserved Ejection Fraction Using Multimodal Real-World DataStudy in peopleBiomarkersPaper